Brief News: WUXI XDC issues profit warning, expects last year's profit to increase by 38%
I'm PortAI, I can summarize articles.
WUXI XDC Biotechnology Co., Ltd. expects a 45% year-on-year increase in total revenue for the full year of 2025, with a net profit growth of 38%, mainly due to optimized product and service profit margins and effective cost control. The company also proposed to acquire Voyah at HKD 4 per share, totaling approximately HKD 2.79 billion, with the acquisition price being 60% higher than before the suspension of trading. WUXI XDC's stock price fell 2.3% to HKD 74, while Voyah's stock price surged 58.8% to HKD 3.97
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: BambooWorks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments